Vaccination against SARS-CoV-2 Does Not Protect against the Development of Anosmia in a Hamster Model
Anosmia, a total or partial loss of the ability to smell, is one of the most frequently documented sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Persistent anosmia is associated with a decrease in quality of life. Here, we assess the impact of virus lineage and...
Main Authors: | Rachel A. Reyna, Jordyn Walker, Brooke Mitchell, Divya P. Shinde, Jessica A. Plante, Scott C. Weaver, Kenneth S. Plante |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/10/1564 |
Similar Items
-
Ontological Anosmia
by: Andreas Philippopoulos-Mihalopoulos
Published: (2021-12-01) -
SUDDEN ANOSMIA - HIDDEN INTIMATION OF NOVEL CORONAVIRUS
by: Sana Abbas, et al.
Published: (2020-09-01) -
Radio-laboratory findings in COVID-19 anosmia patients: a single-center experience
by: Tareq Muhammad Algarf, et al.
Published: (2021-07-01) -
Bilateral olfactory aplasia: Uncommon cause of congenital anosmia
by: Ashraf Nabeel Mahmood, et al.
Published: (2019-07-01) -
Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters
by: Rafael R. G. Machado, et al.
Published: (2023-07-01)